These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34304300)

  • 1. Sirolimus in infants with congenital hyperinsulinism (CHI) - a single-centre experience.
    Panigrahy N; Chirla DK; Bagga N; Gunda RK; Sukhija B; Reddy L
    Eur J Pediatr; 2022 Jan; 181(1):407-412. PubMed ID: 34304300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia.
    Abraham MB; Shetty VB; Price G; Smith N; Bock Md; Siafarikas A; Resnick S; Whan E; Ellard S; Flanagan SE; Davis EA; Jones TW; Hussain K; Choong CS
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1391-8. PubMed ID: 26226122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus Therapy and Follow-up in a Patient with Severe Congenital Hyperinsulinism Following Subtotal Pancreatectomy.
    Chen Q; Chen Y; Wang X; Yang H; Zhang Y; Liu X; Yan Y; Wei H
    J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):119-123. PubMed ID: 32482020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation.
    Shah P; Arya VB; Flanagan SE; Morgan K; Ellard S; Senniappan S; Hussain K
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):695-9. PubMed ID: 25518065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus.
    Ünal S; Gönülal D; Uçaktürk A; Siyah Bilgin B; Flanagan SE; Gürbüz F; Tayfun M; Elmaoğulları S; Araslı A; Demirel F; Ellard S; Hussain K
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):478-481. PubMed ID: 27181099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and management of neonatal onset hyperinsulinemic hypoglycemia: a single neonatal center experience.
    Bezirganoglu H; Okur N; Celik K; Tas FF; Ozbek MN
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2272014. PubMed ID: 37860935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
    Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
    Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia.
    Senniappan S; Alexandrescu S; Tatevian N; Shah P; Arya V; Flanagan S; Ellard S; Rampling D; Ashworth M; Brown RE; Hussain K
    N Engl J Med; 2014 Mar; 370(12):1131-7. PubMed ID: 24645945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus Therapy in Congenital Hyperinsulinism: A Successful Experience Beyond Infancy.
    Minute M; Patti G; Tornese G; Faleschini E; Zuiani C; Ventura A
    Pediatrics; 2015 Nov; 136(5):e1373-6. PubMed ID: 26504125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.
    Salomon-Estebanez M; Flanagan SE; Ellard S; Rigby L; Bowden L; Mohamed Z; Nicholson J; Skae M; Hall C; Craigie R; Padidela R; Murphy N; Randell T; Cosgrove KE; Dunne MJ; Banerjee I
    Orphanet J Rare Dis; 2016 Dec; 11(1):163. PubMed ID: 27908292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation.
    Kiff S; Babb C; Guemes M; Dastamani A; Gilbert C; Flanagan SE; Ellard S; Barton J; Dattani M; Shah P
    Endocrinol Diabetes Metab Case Rep; 2019 Feb; 2019():. PubMed ID: 30753133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancy.
    Brown RE; Senniappan S; Hussain K; McGuire MF
    Orphanet J Rare Dis; 2017 Dec; 12(1):181. PubMed ID: 29246172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to sirolimus in a case of diffuse congenital hyperinsulinaemic hypoglycaemia due to homozygous
    Oza CM; Khadilkar V; Kadam S; Khadilkar A
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36410788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus precipitating diabetes mellitus in a patient with congenital hyperinsulinaemic hypoglycaemia due to autosomal dominant ABCC8 mutation.
    Dastamani A; Güemes M; Walker J; Shah P; Hussain K
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1219-1222. PubMed ID: 28985184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: Exceptional transmission of congenital hyperinsulinism from a focal CHI mother to her diffuse CHI dichorionic diamniotic twins.
    Telehuz D; Plesa O; Bouilloud F; Wucher H; De Lonlay P; Bérat CM; Saint-Martin C; Dupuy O; Arnoux JB
    Front Endocrinol (Lausanne); 2024; 15():1408003. PubMed ID: 38952388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hyperinsulinism: management and outcome, a single tertiary centre experience.
    El Tonbary K; Robinson P; Banerjee I; Shaikh MG
    Eur J Pediatr; 2020 Jun; 179(6):947-952. PubMed ID: 32002613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine in Congenital Hyperinsulinism - A Case Report.
    Khawash P; Hussain K; Flanagan SE; Chatterjee S; Basak D
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):151-4. PubMed ID: 26316440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic Success.
    Szymanowski M; Estebanez MS; Padidela R; Han B; Mosinska K; Stevens A; Damaj L; Pihan-Le Bars F; Lascouts E; Reynaud R; Ferreira C; Bansept C; de Lonlay P; Saint-Martin C; Dunne MJ; Banerjee I; Arnoux JB
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4719-4729. PubMed ID: 27691052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation.
    Korula S; Chapla A; Priyambada L; Mathai S; Simon A
    J Pediatr Endocrinol Metab; 2018 Jan; 31(1):87-89. PubMed ID: 29176012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.